Latest Asx News

Cyclone Metals advances its flagship Iron Bear Project despite a minor delay in drilling caused by First Nations election disputes, while strengthening its cash position through significant share sales.

BMG Resources reports encouraging drill results and advances a scoping study at Abercromby, while Bullabulling drilling confirms multiple gold lodes and potential resource expansion. A recent $600,000 placement supports ongoing development.

Locate Technologies proposes a scheme to migrate its listing from ASX to NZX, enabling continuation of its Bitcoin Treasury Strategy without ASX restrictions. The move aims to broaden investor base and enhance shareholder value.

Tombador Iron Limited is set to transform into Atomic Eagle Limited through its acquisition of GoviEx Uranium Inc, creating a new ASX-listed uranium explorer focused on Africa’s Muntanga Project. A capital raise of up to A$10 million will underpin this strategic pivot.

Complii FinTech Solutions reported a 4.9% year-on-year increase in annual recurring revenue, progressed a major CRM system upgrade, and secured a $1.217 million R&D rebate in Q1 FY26, while managing cash flow pressures.

Admiralty Resources NL reported a mixed cash flow quarter ending September 2025, balancing operating outflows with investing and financing inflows to maintain a solid funding runway.

Admiralty Resources NL reported steady production growth at its Mariposa Iron Ore Project in Chile, securing key export approvals and infrastructure progress despite a delay in its audited financial statements that led to ASX suspension.

Gateway Mining has completed its acquisition of the Yandal Gold Project, revealing promising high-grade gold results and securing $22.5 million to fuel extensive exploration and drilling programs.

Adherium Limited reports a strong quarter with a 55% increase in device shipments and groundbreaking clinical results from its iCARE study, alongside securing over $2.6 million in post-quarter funding.

Toro Energy has agreed to be acquired by IsoEnergy in a deal valuing Toro shares at a 79.7% premium, combining uranium assets across Australia, Canada, and the US. The transaction promises enhanced scale and exposure to tier-one uranium projects, pending shareholder and regulatory approvals.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.

Pure Foods Tasmania reported a $1 million operating cash outflow in the September quarter due to restructuring and timing factors but anticipates positive cash flow and growth driven by new Coles product launches and operational efficiencies.